MA38709A1 - Compositions et procédés pour une utilisation en diagnostic médical - Google Patents
Compositions et procédés pour une utilisation en diagnostic médicalInfo
- Publication number
- MA38709A1 MA38709A1 MA38709A MA38709A MA38709A1 MA 38709 A1 MA38709 A1 MA 38709A1 MA 38709 A MA38709 A MA 38709A MA 38709 A MA38709 A MA 38709A MA 38709 A1 MA38709 A1 MA 38709A1
- Authority
- MA
- Morocco
- Prior art keywords
- nanoparticles
- nanoparticle
- aggregates
- compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0457—Semi-solid forms, ointments, gels, hydrogels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
La présente invention concerne des compositions et des procédés pour une utilisation en diagnostic médical et en suivi de patient. Elle concerne plus particulièrement un gel biocompatible comprenant des nanoparticules et/ou des agrégats de nanoparticules, i) la nanoparticule et/ou l'agrégat de nanoparticules comprenant un matériau inorganique comprenant au moins un élément métallique présentant un nombre atomique z d'au moins 25, chacun parmi ladite nanoparticule et/ou ledit agrégat de nanoparticules étant recouvert d'un revêtement biocompatible ; ii) la concentration en nanoparticules et/ou en agrégats de nanoparticules étant d'environ ou inférieure à 0,5 % (p/p) ; et iii) la viscosité apparente à 2s-1 du gel comprenant des nanoparticules et/ou des agrégats de nanoparticules étant située entre environ 0,1 pa.S et environ 1000 pa.S lorsqu'elle est mesurée entre 20°c et 37°c. La composition de l'invention permet généralement la délimitation et la visualisation d'au moins 40 % du tissu biologique cible lorsque ledit tissu est observé à l'aide d'un équipement d'imagerie par rayons x.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305831 | 2013-06-20 | ||
| PCT/EP2014/062947 WO2014202723A1 (fr) | 2013-06-20 | 2014-06-19 | Compositions et procédés pour une utilisation en diagnostic médical |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA38709A1 true MA38709A1 (fr) | 2018-05-31 |
Family
ID=48745869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA38709A MA38709A1 (fr) | 2013-06-20 | 2014-06-19 | Compositions et procédés pour une utilisation en diagnostic médical |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10588987B2 (fr) |
| EP (1) | EP3010495B1 (fr) |
| JP (1) | JP6560665B2 (fr) |
| KR (1) | KR20160027009A (fr) |
| CN (1) | CN105431141A (fr) |
| AU (1) | AU2014283217A1 (fr) |
| BR (1) | BR112015031977A2 (fr) |
| CA (1) | CA2915430A1 (fr) |
| EA (1) | EA201690050A1 (fr) |
| HK (1) | HK1222562A1 (fr) |
| MA (1) | MA38709A1 (fr) |
| MX (1) | MX2015017774A (fr) |
| SG (1) | SG11201510021TA (fr) |
| WO (1) | WO2014202723A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201403096VA (en) | 2011-12-16 | 2014-07-30 | Nanobiotix | Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof |
| AR104806A1 (es) | 2015-05-28 | 2017-08-16 | Nanobiotix | Nanopartículas para uso como vacuna terapéutica |
| CN105097174B (zh) * | 2015-08-12 | 2018-06-22 | 华南理工大学 | 一种木聚糖季铵盐纳米磁性颗粒及其制备方法 |
| AU2017384425B2 (en) * | 2016-12-21 | 2023-08-31 | Nanobiotix | Nanoparticles for use for treating a neuronal disorder |
| MX2019007607A (es) * | 2016-12-21 | 2019-08-29 | Nanobiotix | Nanoparticulas para su uso para potenciar rendimientos del cerebro o para tratar estres. |
| KR101949347B1 (ko) * | 2017-05-24 | 2019-02-18 | 이화여자대학교 산학협력단 | 유방암의 재발 예측을 위한 정보제공방법 |
| US11116793B2 (en) * | 2017-11-13 | 2021-09-14 | National University Corporation Hokkaido University | Modified metal nanoparticle comprising cyclic polyether and pharmaceutical composition |
| CN107998395A (zh) * | 2017-12-14 | 2018-05-08 | 天津市赛宁生物工程技术有限公司 | 一种双功能乳腺靶标及制备方法 |
| WO2024126383A1 (fr) | 2022-12-12 | 2024-06-20 | Nanobiotix (Nanobiotix S.A.) | Nouvelles nanoparticules d'oxyde métallique et compositions de celles-ci destinées à être utilisées en tant que radioactivateurs ou pour visualiser un tissu biologique |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6161034A (en) | 1999-02-02 | 2000-12-12 | Senorx, Inc. | Methods and chemical preparations for time-limited marking of biopsy sites |
| US20050084869A1 (en) * | 2003-10-20 | 2005-04-21 | Sung Hyun Kim | Novel composition and methods for the diagnosis of lung cancer |
| FR2869803B1 (fr) * | 2004-05-10 | 2006-07-28 | Nanobiotix Sarl | Particules activables, preparation et utilisations |
| DE102006041495A1 (de) | 2006-08-29 | 2008-03-20 | Friedrich-Schiller-Universität Jena | Substanzgemisch zur lokalen Deposition von Magnetpartikeln in einem Medium, insbesondere in tumorbefallenem organischem Gewebe, sowie Applikationskit zur Verabreichung |
| DE102008008522A1 (de) * | 2008-02-11 | 2009-08-13 | Magforce Nanotechnologies Ag | Implantierbare Nanopartikel-enthaltende Produkte |
| EP2130553A1 (fr) | 2008-06-05 | 2009-12-09 | Nanobiotix | Nanoparticules inorganiques de haute densité pour détruire des cellules in-vivo |
| EP2275137A1 (fr) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Nanoparticules métalliques, leur préparation et utilisations |
| JP5820815B2 (ja) | 2009-12-15 | 2015-11-24 | インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ | インプラントおよび生体分解性基準マーカー |
| US10064960B2 (en) | 2011-11-25 | 2018-09-04 | Danmarks Tekniske Universitet | Formulation of solid nano-sized particles in a gel-forming system |
| SG11201403096VA (en) * | 2011-12-16 | 2014-07-30 | Nanobiotix | Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof |
| US20140219926A1 (en) * | 2013-02-01 | 2014-08-07 | The Trustees Of Dartmouth College | Biodegradable Iron Oxide Nanoparticle Gel for Tumor Bed Therapy |
| SG11201510468TA (en) * | 2013-06-20 | 2016-01-28 | Nanobiotix | Compositions and methods for use in oncology |
-
2014
- 2014-06-19 MA MA38709A patent/MA38709A1/fr unknown
- 2014-06-19 AU AU2014283217A patent/AU2014283217A1/en not_active Abandoned
- 2014-06-19 EP EP14731285.4A patent/EP3010495B1/fr active Active
- 2014-06-19 SG SG11201510021TA patent/SG11201510021TA/en unknown
- 2014-06-19 JP JP2016520491A patent/JP6560665B2/ja active Active
- 2014-06-19 MX MX2015017774A patent/MX2015017774A/es unknown
- 2014-06-19 US US14/898,763 patent/US10588987B2/en active Active
- 2014-06-19 CA CA2915430A patent/CA2915430A1/fr not_active Abandoned
- 2014-06-19 EA EA201690050A patent/EA201690050A1/ru unknown
- 2014-06-19 BR BR112015031977A patent/BR112015031977A2/pt not_active IP Right Cessation
- 2014-06-19 KR KR1020167001660A patent/KR20160027009A/ko not_active Application Discontinuation
- 2014-06-19 WO PCT/EP2014/062947 patent/WO2014202723A1/fr active Application Filing
- 2014-06-19 CN CN201480034960.8A patent/CN105431141A/zh active Pending
-
2016
- 2016-09-12 HK HK16110780.5A patent/HK1222562A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016527204A (ja) | 2016-09-08 |
| CN105431141A (zh) | 2016-03-23 |
| US10588987B2 (en) | 2020-03-17 |
| MX2015017774A (es) | 2016-03-31 |
| BR112015031977A2 (pt) | 2017-07-25 |
| WO2014202723A1 (fr) | 2014-12-24 |
| JP6560665B2 (ja) | 2019-08-14 |
| CA2915430A1 (fr) | 2014-12-24 |
| KR20160027009A (ko) | 2016-03-09 |
| EP3010495A1 (fr) | 2016-04-27 |
| AU2014283217A1 (en) | 2015-12-24 |
| HK1222562A1 (zh) | 2017-07-07 |
| US20160136303A1 (en) | 2016-05-19 |
| EA201690050A1 (ru) | 2016-05-31 |
| SG11201510021TA (en) | 2016-01-28 |
| EP3010495B1 (fr) | 2021-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA38709A1 (fr) | Compositions et procédés pour une utilisation en diagnostic médical | |
| Huang et al. | Micro-CT and nano-CT analysis of filling quality of three different endodontic sealers | |
| Jafari et al. | Importance and methodologies of endodontic microleakage studies: A systematic review | |
| Diem et al. | The effect of a nano-filled resin coating on the 3-year clinical performance of a conventional high-viscosity glass-ionomer cement | |
| Unemori et al. | Composite resin restoration and postoperative sensitivity: clinical follow-up in an undergraduate program | |
| Sarkis-Onofre et al. | The role of resin cement on bond strength of glass-fiber posts luted into root canals: a systematic review and meta-analysis of in vitro studies | |
| Javidi et al. | Zinc oxide nano-particles as sealer in endodontics and its sealing ability | |
| Montis et al. | Interaction of nanoparticles with lipid membranes: a multiscale perspective | |
| Matsushita-Tokugawa et al. | Detection of dentinal microcracks using infrared thermography | |
| Nelson et al. | Distribution and chemical speciation of exogenous micro-and nanoparticles in inflamed soft tissue adjacent to titanium and ceramic dental implants | |
| Scotti et al. | Tridimensional evaluation of the interfacial gap in deep cervical margin restorations: a micro-CT study | |
| Sui et al. | Understanding nature’s residual strain engineering at the human dentine–enamel junction interface | |
| Sağlam et al. | Effects of irrigation solutions on the surface of ProTaper instruments: A microscopy study | |
| Farshad et al. | Effect of imidazolium-based silver nanoparticles on root dentin roughness in comparison with three common root canal irrigants | |
| Chisholm et al. | Nanoparticle diffusion in spontaneously expectorated sputum as a biophysical tool to probe disease severity in COPD | |
| Celik et al. | Microtensile bond strength of composite-to-composite repair with different surface treatments and adhesive systems | |
| EA201690042A1 (ru) | Композиции и способы для применения в онкологии | |
| Saghiri et al. | Mechanical response of dental cements as determined by nanoindentation and scanning electron microscopy | |
| Bakhsh et al. | Nondestructive evaluation of microleakage in restored primary teeth using CP-OCT | |
| Bakhsh et al. | Evaluation of the adaptation of dental polymers using cross-polarization optical coherence tomography | |
| Chávez-Lozada et al. | In vitro evaluation of the film thickness of self-etching resin cements | |
| Pahwa et al. | 0409 The North American Pooled Project (NAPP): Pooled analyses of case-control studies of pesticides and agricultural exposures, lymphohematopoietic cancers and sarcoma | |
| Abdinian et al. | Comparison of dental and skeletal indices between patients under haemodialysis and peritoneal dialysis with healthy individuals in digital panoramic radiography | |
| CRISTIAN et al. | JAW BONE ATROPHY INDUCED BY EXPOSURE TO TOXIC ENVIRONMENT USING RADIOLOGICAL INTERPRETATION. | |
| KUMAR et al. | Bifid Rib–Boon Or Bane |